contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


micropos-medical-st-lukes-hospital-in-dublin-starts-asbrt-treatments-using-raypilot-system

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Micropos Medical operates in medical technology. The company's products are used in radiotherapy. The vision is to develop a technology that will pinpoint diseases during said treatment, where product development is based on an electromagnetic positioning system. The product creates real-time information and is used primarily for the treatment of prostate cancer, but also for other tumor treatments. The company was established in 2003 and has its headquarters in Gothenburg.

Micropos Medical

Treatment with ASBRT (Augmented Stereotactic Body Radiotherapy) and the Raypilot® System has now begun at St Luke's Hospital in Dublin. Last Friday, the treatment of the first patient was successfully...

<div class="abstract">Treatment with ASBRT (Augmented Stereotactic Body Radiotherapy) and the Raypilot® System has now begun at St Luke's Hospital in Dublin. Last Friday, the treatment of the first patient was successfully completed with a team from Micropos Medical present on site.</div>As previously announced, St Luke's Hospital has entered into a rental agreement for the Raypilot System in order to evaluate the technology while integrating five-fraction SBRT into its daily clinical workflow. The objective is for ASBRT to become part of the standard treatment for prostate cancer at the clinic.Dr Alex Boychak, Radiation Oncologist in charge at the Dublin clinic, is very pleased and comments:"With the Raypilot System, we can see exactly where we are delivering the radiation. Being able to deliver the dose in the right place at the right time gives us confidence in the treatment. Above all, this allows our patients to benefit from a safe, modern and efficient treatment method with a reduced risk of side effects."Highlighting patient benefits of modern radiotherapy Micropos Medical is actively working to raise awareness of modern radiotherapy as a relevant treatment option for prostate cancer, offering advantages for both patients and healthcare providers."There is now substantial evidence that modern radiotherapy is a safe and effective prostate cancer treatment, providing significant benefits for patients. We want to increase knowledge and awareness of this. For us, the start at St Luke's Hospital represents an important milestone, and we are pleased to see ASBRT begin to be adopted as a standard treatment. The more patients who gain access to this method, the better," says Richard Forsberg, CEO of Micropos Medical.<div></div>

Micropos Medical: St Luke's Hospital in Dublin starts ASBRT Treatments Using Raypilot System